Daily Filing Digest — Thursday, 20 Aug 2026

1,169 filings screened from yesterday's Day Pack — 7 rated HIGH by the desks, 212 MEDIUM — with 25 primary documents pulled and read and 97 evidence rows extracted. Two articles today: a founder answering the copyability question with an itemised list (Lenskart), and the week's third live pricing-power test (IFB). Three HIGH-triage corporate events clear the bar alongside the transcripts.

Today's filings

• LENSKART (Lenskart Solutions) — Q1 FY27 call: founder Peyush Bansal enumerates, unprompted, what serving "6,100 unserved pin codes actually demands" — manufacturing, design, distribution, logistics, omnichannel, eye testing, brands, data, capital — and notes the company has entered 152 cities "over 2,650 remain" with supply chain and brand already running. Products below ₹1,000 are new to the range; share gains are "just beginning." (Filed transcript, 19-Aug-2026, p.7, p.3, p.8)
• IFBIND (IFB Industries) — Q1 FY27 call: price increases taken "across all our categories" — and still, in the MD's words, "we have not been able to pass on the commodity and Forex to the customer." Revenue +16.65% to ₹1,529 cr with margins repaired mainly by a ₹150 cr cost programme (₹42 cr done in Q1). The third live pricing-power test filed this week, and the day's second article. (Filed transcript, 19-Aug-2026, p.4, p.11)
• AEGISLOG / AEGISVOPAK (Aegis Logistics · Aegis Vopak Terminals) — the same-day transcript pair describes long-dated contracted revenue on import infrastructure: two 15-year take-or-pay agreements (one with Hindustan Zinc) and an exclusive HPCL Haldia arrangement at Vopak, and record LPG volumes (+91% YoY) with per-ton EBITDA management attributes to the integrated sourcing-to-distribution platform at Logistics. Both carry our first-pass scores: Aegis Logistics 5.49 · Aegis Vopak 5.20, both NARROW. The counterweight is a ~$5 bn capex pipeline against the current EBITDA base. (AEGISLOG transcript · AEGISVOPAK transcript)
• FLUOROCHEM (Gujarat Fluorochemicals) — Q1 FY27 call: fluoropolymer growth of 15% YoY attributed to moving up the value-added chain and "capturing share vacated by 3M," with AGC's UK exit "now generating new customer queries" — and the switching-cost mechanism stated alongside: high-end products carry longer qualification cycles. Two global competitors retreating from a qualification-locked product line is structural, not cyclical. Our first-pass read: 5.61, NARROW trending wide. (Filed transcript, 19-Aug-2026)
• SAMMAANCAP (Sammaan Capital) — Q1 FY27 call: cost of funds down ~90 bps post-transition, worth ~₹450 cr annualised and rising toward ~₹1,000 cr per management, alongside domestic and international rating upgrades. The mirror image of Finkurve's admission below — in lending, the funding line is the moat. Our read: 4.82, NARROW. (Filed transcript, 19-Aug-2026)
• HONASA (Honasa Consumer) — Q1 FY27 call: management cites its highest-ever Kantar brand-power score, a second brand crossing ₹1,000 cr ARR, and offline share gains of 350 bps in face washes and 160 bps in shampoos. Brand-dimension evidence worth tracking against the pricing test rather than taking as its conclusion. Our read: 5.57, NARROW trending wide. (Filed transcript, 19-Aug-2026)
• EMSLIMITED (EMS Ltd) — Q1 FY27 call, the adverse read: management acknowledged competition is increasing and that margins "cannot come to that level" of FY24, with heavy state-government customer concentration. An order book of ₹2,329 cr does not offset a stated margin ceiling. (Filed transcript, 19-Aug-2026)
• TMPV (Tata Motors Passenger Vehicles) — per the filed transcript: overall PV share up 200 bps YoY to 14.3%, holding the #2 position, on India revenue of ₹18,000 cr (+65%); in EVs specifically, volumes doubled over the year and share was maintained and grown "upwards of 40% despite increased competition." The concession on the record: "all the competitors are finding the China market extremely difficult, and we are also impacted." (Filed transcript, 19-Aug-2026)
• LANDMARK (Landmark Cars) — Q1 FY27 call: luxury-car retail's ceiling stated plainly — the market "has been kind of hovering around 50,000 units" — with the counter-thesis that new entrants "generally expand the market." (Filed transcript, 19-Aug-2026, p.6)
• FINKURVE (Finkurve Financial Services) — Q1 FY27 call, per the filed transcript: an unusually candid competitive self-assessment — "there were always players who have better cost of funds, better brand," with differentiation now resting primarily on product. Lending without a funding-cost edge is the hardest seat at the table; staged for the watchlist. (Filed transcript, 19-Aug-2026, p.10)
• LTTS (L&T Technology Services) — secured a 5-year engagement valued at over $75 million from an unnamed global technology enterprise, spanning product engineering through platform operations, including a dedicated Engineering Center. A multi-year embedded engagement is switching-cost territory — though with the customer unnamed, depth over breadth is the honest read. (Exchange filing, 19-Aug-2026)
• ABDL (Allied Blenders and Distillers) — India Ratings upgraded its bank facilities two notches, IND A → IND AA- (Stable), citing "strong market position in the IMFL industry" and pan-India diversification. External validation of the brand/position claim, from a party paid to be sceptical. (Press release filing, 19-Aug-2026)
• CEIGALL (Ceigall India) — five Letters of Acceptance totalling ₹2,423.7 cr on the NH-913 Frontier Highway corridor in Arunachal Pradesh, inside two days. A material order-book event; no bid-pricing data disclosed, so execution capability — not pricing power — is what it evidences. (Press release filing, 19-Aug-2026)

Also flagged: Minda Corporation's record ₹1,846 cr quarter (+33% vs industry +22%) with margin held; Vinny Overseas received a customs show-cause alleging import mis-declaration (an allegation, not a finding — watchlist); Shri Niwas Leasing lost both Independent Directors in one day, replaced by a non-independent appointee.

From today's filings

Today's articles: "The Cost of Copying Lenskart, in Its Founder's Own Words" — the nine-item replication bill read against the sceptic's case and our published 5.51 first-pass score — and "IFB Raised Prices Everywhere — and Still Couldn't Cover Its Costs", the case that sits exactly between Monday's two poles. Staged for Sunday's Weekly Filing Digest: the Lenskart inventory passage (THE RECEIPTS candidate) and Finkurve's cost-of-funds admission (THE FINE PRINT candidate — the mitigating fact is that management said it about themselves).

Educational research, not investment advice. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.